Related Experiment Video
Updated: Jun 25, 2026

11:40
Quantitative Autonomic Testing
Published on: July 19, 2011
Quantitative autonomic testing in the management of botulism
Raffi Topakian1, Christoph Heibl, Karl Stieglbauer
1Department of Neurology, Academic Teaching Hospital Wagner-Jauregg, Wagner-Jauregg-Weg 15, Linz 4020, Austria. raffi.topakian@hotmail.com
Journal of Neurology
|February 26, 2009
Summary
Quantitative autonomic testing (QAT) revealed significant autonomic dysfunction in botulism patients, even with mild neurological symptoms. This testing aids in managing botulism by identifying autonomic involvement.
Area of Science:
- Neurology
- Autonomic Neuroscience
Background:
- Botulism, a neuroparalytic illness, often presents with autonomic symptoms despite mild neurological signs.
- Quantitative Autonomic Testing (QAT) can assess sudomotor and cardiovascular reflex functions.
Observation:
- Five food-borne botulism patients underwent QAT, autonomic symptom questionnaires, and examinations at baseline and follow-up.
- Autonomic complaints were more severe than neurological deficits.
- Baseline QAT showed impaired sudomotor function, heart rate variability, and blood pressure regulation.
Findings:
- Patients exhibited high resting heart rate, supine hypertension, orthostatic hypotension, and impaired baroreflex function.
- Three patients experienced reduced physical capacity.
- Follow-up QAT indicated significant improvement in cardiovascular autonomic function.
Implications:
- QAT effectively identifies autonomic dysfunction in botulism, even with subtle neurological findings.
- Comprehensive autonomic evaluation is crucial for effective botulism management.
- Findings inform rehabilitation strategies for botulism survivors.
Related Concept Videos
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

